Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Notice Convening Extra-Ordinary General Meeting("EGM") Of The Fredun Pharmaceuticals Limited ('The Company')

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we enclose herewith the Notice of the Extra-Ordinary General Meeting scheduled to be held as under: Day & Date: Friday, 23rd September, 2022 Time : 09:00 A.M (IST) Mode : Through Video Conferencing ('VC') or/ Other Audio-Visual Means ('OAVM'). Details of joining the meeting are provided in the enclosed Notice of the EGM. The Notice of the EGM is also placed on the website of the Company at www.fredungroup.com We request you to take the same on your record.
01-09-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 and 47 read with Schedule III Para A, of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in compliance with relevant circulars issued by Ministry of Corporate Affairs and the Securities and Exchange Board of India, we enclose the copies of the following newspaper advertisements published for giving information regarding the Extra-Ordinary General Meeting of the Company scheduled to be held on Friday, 23" September, 2022 at 09:00 a.m. through Video Conference/ Other Audio-Visual Means only, along with e-voting details, procedure for registering the e-mail addresses and procuring the user id and password for e-voting: a. Active Times (English) b. Mumbai Lakshadeep (Marathi) Please take the above on record.
29-08-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 27, 2022 Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')

 Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company at their meeting held on Saturday, August 27, 2022 has inter-alia approved the option of fund raising through Preferential Issue. The Board Meeting commenced at 8.30 p.m. and was concluded at 11.00 p.m. Kindly take the same on record.
27-08-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window

 Revised Intimation of closure of trading window Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, and "Code of Conduct for Prevention of Insider Trading" of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company), the trading window for dealing in securities of the Company will remain closed for designated persons and their immediate relatives with effect from Thursday, August 25, 2022 till 48 hours after the end of the Board Meeting wherein; the approval for raising funds by way of preferential allotment of Equity Shares, would be considered, approved and declared. The said information is being notified to all designated persons under the above Regulations. Kindly take the same on your Records.
25-08-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window

 Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, and 'Code of Conduct for Prevention of Insider Trading' of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company), the trading window for dealing in securities of the Company will remain closed for designated persons and their immediate relatives with effect from Thursday, February 25, 2022 till 48 hours after the end of the Board Meeting wherein; the approval for raising funds by way of preferential allotment of Equity Shares, would be considered, approved and declared. The said information is being notified to all designated persons under the above Regulations. Kindly take the same on your Records.
24-08-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Prior Intimation For Fund Raising By Way Of Preferential Allotment

 Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/08/2022 ,inter alia, to consider and approve Pursuant to Reg 29(1)(d) of the SEBI (LODR) Reg, 2015, meeting of the board of directors of Fredun Pharmaceuticals Limited is on Saturday, 27/8/22 to consider a proposal for issuance of equity shares &/or warrants by way of a preferential allotment, in accordance with the provisions of the SEBI (ICDR) Reg, 2018 & the Companies Act, 2013, as amended, subject to such regulatory/ statutory approvals as may be required. This is to further inform you that as per Reg 9 of the SEBI (PIT) Reg, 2015 & the Company''s Code of Conduct for PIT framed in accordance with the SEBI (PIT) Regulations, 2015, as amended from time to time, the trading window for dealing in the securities shall remain closed from Thursday, 25/8/22 till the end of 48 hrs from the conclusion of the BM both days inclusive for all connected persons/ officers/ designated employees/ insiders, directors of the Company & immediate relatives of these persons, including but not limited to the persons specified in the Company''s COC
24-08-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015

 Dear Sir/ Madam, Please find enclosed herewith information required under Regulation 30 of SEBI (LODR) Regulations, 2015: "Business Update of Fredun Pharmaceuticals Limited" We request you to take the above information on your records.
24-08-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Financial Results For The Quarter Ended 30Th June, 2022

 We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Friday, 12th August, 2022 at 3:00 pm had considered and approved the following items of Business: 1. In compliance to Regulation 30 and 33 of SEBI Listing Regulations, 2015; the Un-Audited Financial Results of the Company for the quarter ended 30th June, 2022; along with the Limited Review Report as issued by M/s Savla & Associates; Statutory Auditors of the Company; copies of which are attached hereunder; The Meeting of the Board Commenced at 3:00 P.M. and concluded at 06:50 P.M. Kindly oblige and take the same on your Records.
12-08-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome Of Board Meeting Dated 12Th August, 2022

 We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Friday, 12th August, 2022 at 3:00 pm had considered and approved the following items of Business: 1. In compliance to Regulation 30 and 33 of SEBI Listing Regulations, 2015; the Un-Audited Financial Results of the Company for the quarter ended 30th June, 2022; along with the Limited Review Report as issued by M/s Savla & Associates; Statutory Auditors of the Company; copies of which are attached hereunder; The Meeting of the Board Commenced at 3:00 P.M. and concluded at 06:50 P.M. Kindly oblige and take the same on your Records.
12-08-2022
Bigul

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Board Meeting Of The Company On Friday, 12Th August, 2022

 Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 12th August 2022 at 3.00 p.m. at the Corporate Office of the Company to transact inter - alia the following businesses: 1) To discuss, consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June, 2022. 2) Any other matter with the permission of the Chair Kindly take the same on your records.
05-08-2022
Next Page
Close

Let's Open Free Demat Account